DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14:32.

Article  PubMed  PubMed Central  Google Scholar 

Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15:40.

Article  PubMed  PubMed Central  Google Scholar 

Ferrari C, Sorbi S. The complexity of Alzheimer’s disease: an evolving puzzle. Physiol Rev. 2021;101:1047–81.

Article  PubMed  CAS  Google Scholar 

Peterson A, Clapp J, Harkins K, Kleid M, Largent EA, Stites SD, et al. Is there a difference between terminal lucidity and paradoxical lucidity? Alzheimers Dement. 2022;18:540–1.

Article  PubMed  Google Scholar 

Habashi M, Vutla S, Tripathi K, Senapati S, Chauhan PS, Haviv-Chesner A, et al. Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble abeta oligomers. Proc Natl Acad Sci U S A. 2022;119:e2210766119.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Peterson A, Clapp J, Largent EA, Harkins K, Stites SD, Karlawish J. What is paradoxical lucidity? The answer begins with its definition. Alzheimers Dement. 2022;18:513–21.

Article  PubMed  Google Scholar 

Vardalaki D, Chung K, Harnett MT. Filopodia are a structural substrate for silent synapses in adult neocortex. Nature. 2022;612:323–7.

Article  PubMed  CAS  Google Scholar 

Ji X, Zhou Y, Gao Q, He H, Wu Z, Feng B, et al. Functional reconstruction of the basal ganglia neural circuit by human striatal neurons in hypoxic-ischaemic injured brain. Brain. 2023;146:612–28.

Article  PubMed  Google Scholar 

Cheng D, Lei ZG, Chu K, Lam OJH, Chiang CY, Zhang ZJ. N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk. Alzheimers Res Ther. 2024;16:95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moliner R, Girych M, Brunello CA, Kovaleva V, Biojone C, Enkavi G, et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat Neurosci. 2023;26:1032–41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nardou R, Sawyer E, Song YJ, Wilkinson M, Padovan-Hernandez Y, de Deus JL, et al. Psychedelics reopen the social reward learning critical period. Nature. 2023;618:790–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang YY, Gan YH, Yang L, Cheng W, Yu JT. Depression in Alzheimer’s Disease: Epidemiology, mechanisms, and treatment. Biol Psychiatry. 2024;95:992–1005.

Article  PubMed  CAS  Google Scholar 

Vann Jones SA, O’Kelly A. Psychedelics as a treatment for Alzheimer’s Disease Dementia. Front Synaptic Neurosci. 2020;12:34.

Article  PubMed  PubMed Central  Google Scholar